Sensitivity and predictivity in immunotoxicity testing: immune endpoints and disease resistance

被引:33
作者
Germolec, DR [1 ]
机构
[1] NIEHS, Mol Toxicol Lab, Res Triangle Pk, NC 27709 USA
关键词
immunotoxicity; disease resistance; infection; neoplasia; rodents;
D O I
10.1016/j.toxlet.2003.12.025
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
In spite of extensive laboratory data on the effects of chemicals and drugs on immunologic parameters in laboratory animals, and a well established correlation between suppression of immune function and increased incidence and/or severity of certain infectious and neoplastic diseases, interpreting data from experimental immunotoxicology studies for risk assessment purposes has proved challenging. This is particularly true when the immunological effects are minimal-to-moderate in nature, as might be expected from inadvertent chemical exposures. This review examines the methods used to evaluate immune responses in laboratory rodents and their utility to predict disease outcomes. The available data suggest that if a large enough population is exposed and that the challenge dose or virulence of pathogenic organisms or tumor cells is sufficient, small changes in immune surveillance could increase the background incidence and burden of disease in the human population. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 35 条
[1]  
BRADLEY SG, 1995, METHODS IMMUNOTOXICO, V2, P169
[2]   Assessment of immunotoxicity by multiparameter flow cytometry [J].
Burchiel, SW ;
Kerkvliet, NL ;
Gerberick, GF ;
Lawrence, DA ;
Ladics, GS .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1997, 38 (01) :38-54
[3]  
Dayan AD, 1998, TOXICOLOGY, V125, P183
[4]  
*FOOD DRUG ADM, 2002, GUID IND IMM EV INT
[5]   A model of human whole blood lymphokine release for in vitro and ex vivo use [J].
Hermann, C ;
von Aulock, S ;
Graf, K ;
Hartung, T .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 275 (1-2) :69-79
[6]   Single-organism model of host defense against infection: A novel immunotoxicologic approach to evaluate immunomodulatory drugs [J].
Herzyk, DJ ;
Ruggieri, EV ;
Cunningham, L ;
Polsky, R ;
Herold, C ;
Klinkner, AM ;
Badger, A ;
Kerns, WD ;
Bugelski, PJ .
TOXICOLOGIC PATHOLOGY, 1997, 25 (04) :351-362
[7]  
Hickman-Davis JM, 2001, NEWS PHYSIOL SCI, V16, P19
[8]  
*JPMA, 1999, INT TRENDS IMM STUD, V92
[9]   Quantifying the relationship between multiple immunological parameters and host resistance: Probing the limits of reductionism [J].
Keil, D ;
Luebke, RW ;
Pruett, SB .
JOURNAL OF IMMUNOLOGY, 2001, 167 (08) :4543-4552
[10]   Histopathologic approaches to detect changes indicative of immunotoxicity [J].
Kuper, CF ;
Harleman, JH ;
Richter-Reichelm, HB ;
Vos, JG .
TOXICOLOGIC PATHOLOGY, 2000, 28 (03) :454-466